|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||

*
From the Servicio de Neumología (Dr. Jiménez-Ruiz), Hospital de la Princesa, Madrid, Spain; Unidad de Neumología (Dr. Masa), Hospital San Pedro de Alcántara, Cáceres, Spain; Servicio de Neumología (Dr. Miravitlles), Hospital General Vall dHebron, Barcelona, Spain; Unidad de Epidemiología Clínica (Dr. Gabriel), Hospital de la Princesa, Madrid, Spain; Servicio de Neumología (Dr. Viejo), Hospital General Yagüe, Burgos, Spain; Servicio de Neumología (Dr. Villasante), Hospital La Paz, Madrid, Spain; and Unidad de Patología Respiratoria (Dr. Sobradillo), Hospital de Cruces, Baracaldo (Vizcaya), Spain.
A complete list of the participants in the IBERPOC study is given in
the Appendix.
Correspondence to: Carlos A Jiménez-Ruiz, MD, PhD, Servicio de Neumología (Unidad de Tabaquismo), Hospital Universitario de la Princesa, C/Diego de León 62, 28006 Madrid, Spain; e-mail: victorina{at}ctv.es
Objective: To ascertain the differences in smoking characteristics between a group of smokers with COPD and another group of healthy smokers, both of which were identified in a population-based epidemiologic study.
Design and participants: This is an epidemiologic, multicenter, population-based study conducted in seven areas of Spain. A total of 4,035 individuals, men and women aged 40 to 69 years, who were selected randomly from a target population of 236,412 subjects, participated in the study.
Interventions: Eligible subjects answered the European Commission for Steel and Coal questionnaire. Spirometry was performed followed by a bronchodilator test when bronchial obstruction was present. The Fagerström questionnaire was used for study of the degree of physical nicotine dependence, and the Prochazka model was followed for analysis of the smoking cessation phase.
Results: Of 1,023 active smokers, 153 (15%) met
the criteria for COPD. Smokers with COPD were more frequently men (odds
ratio [OR], 2.18; 95% confidence interval [CI], 1.21 to 3.95),
were
46 years of age (OR, 1.97; 95% CI, 1.18 to 3.31), had a lower
educational level (OR, 1.96; 95% CI, 1.23 to 3.14), and had smoked
> 30 pack-years (OR, 3.70; 95% CI, 2.42 to 5.65). Smokers with COPD
showed a higher dependence on nicotine than healthy smokers (mean
[± SD] Fagerström test score, 4.77 ± 2.45 vs
3.15 ± 2.38, respectively; p < 0.001) and higher concentrations
of CO in exhaled air (mean concentration, 19.7 ± 16.3 vs
15.4 ± 12.1 ppm, respectively; p < 0.0001).
Thirty-four percent of smokers with COPD and 38.5% of smokers without
COPD had never tried to stop smoking.
Conclusions: Smokers with COPD have higher tobacco consumption, higher dependence on nicotine, and higher concentrations of CO in exhaled air, suggesting a different pattern of cigarette smoking. Cases of COPD among smokers predominate in men and in individuals with lower educational levels. A significant proportion of smokers have never tried to stop smoking; thus, advice on cessation should be reinforced in both groups of smokers.
Key Words: COPD epidemiology smoking smoking cessation
This article has been cited by other articles:
![]() |
L. Pbert Nurse-Conducted Smoking Cessation in Patients With COPD, Using Nicotine Sublingual Tablets and Behavioral Support. Chest, August 1, 2006; 130(2): 314 - 316. [Full Text] [PDF] |
||||
![]() |
P. Tonnesen, K. Mikkelsen, and L. Bremann Nurse-Conducted Smoking Cessation in Patients With COPD Using Nicotine Sublingual Tablets and Behavioral Support. Chest, August 1, 2006; 130(2): 334 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Polosa Smoking cessation: a critical investigative tool in COPD. Eur. Respir. J., April 1, 2006; 27(4): 860 - 861. [Full Text] [PDF] |
||||
![]() |
M. J. Duaso, J. De Irala, and N. Canga Employee's perceived exposure to environmental tobacco smoke, passive smoking risk beliefs and attitudes towards smoking: a case study in a university setting Health Educ. Res., February 1, 2006; 21(1): 26 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Wagena, P. G. Knipschild, M. J. H. Huibers, E. F. M. Wouters, and C. P. van Schayck Efficacy of Bupropion and Nortriptyline for Smoking Cessation Among People at Risk for or With Chronic Obstructive Pulmonary Disease Arch Intern Med, October 24, 2005; 165(19): 2286 - 2292. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Croxton, G. G. Weinmann, R. M. Senior, R. A. Wise, J. D. Crapo, and A. S. Buist Clinical Research in Chronic Obstructive Pulmonary Disease: Needs and Opportunities Am. J. Respir. Crit. Care Med., April 15, 2003; 167(8): 1142 - 1149. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Miravitlles, C. Murio, T. Guerrero, and R. Gisbert Costs of Chronic Bronchitis and COPD: A 1-Year Follow-up Study Chest, March 1, 2003; 123(3): 784 - 791. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Miravitlles Exacerbations of chronic obstructive pulmonary disease: when are bacteria important? Eur. Respir. J., July 1, 2002; 20(36_suppl): 9S - 19s. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |